Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with Z
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| ZEIN | ORAL | TABLET | 9010666 | 80N308T1NN | 5mg | ||
| ZEIN | ORAL | TABLET, COATED | 9010666 | 80N308T1NN | 25mg | ||
| ZEIN | ORAL | TABLET, EXTENDED RELEASE | 9010666 | 80N308T1NN | 810mg | ||
| ZEIN | ORAL | TABLET, FILM COATED | 9010666 | 80N308T1NN | 5.75mg | ||
| ZINC | SUBCUTANEOUS | INJECTION | 7440666 | J41CSQ7QDS | 0.02%w/v | ||
| ZINC ACETATE | SUBCUTANEOUS | INJECTION | 5970456 | FM5526K07A | NA | ||
| ZINC ACETATE | SUBCUTANEOUS | INJECTION, POWDER, FOR SUSPENSION | 5970456 | FM5526K07A | 2.3mg | ||
| ZINC ACETATE | TOPICAL | SWAB | 5970456 | FM5526K07A | NA | ||
| ZINC CARBONATE | SUBCUTANEOUS | INJECTION, POWDER, FOR SUSPENSION | 5263025 | EQR32Y7H0M | 1.6mg | ||
| ZINC CHLORIDE | INTRADERMAL | INJECTION | 7646857 | 86Q357L16B | 7mg | ||
| ZINC CHLORIDE | OPHTHALMIC | SOLUTION | 7646857 | 86Q357L16B | NA | ||
| ZINC CHLORIDE | OPHTHALMIC | SOLUTION/ DROPS | 7646857 | 86Q357L16B | NA | ||
| ZINC CHLORIDE | ORAL | TABLET | 7646857 | 86Q357L16B | 14mg | ||
| ZINC CHLORIDE | SUBCUTANEOUS | INJECTION | 7646857 | 86Q357L16B | 0.02%w/v | ||
| ZINC OXIDE | INTRAVENOUS | SOLUTION | 1314132 | SOI2LOH54Z | 3.11%w/v | ||
| ZINC OXIDE | RECTAL | SUPPOSITORY | 1314132 | SOI2LOH54Z | 375mg | ||
| ZINC OXIDE | RESPIRATORY (INHALATION) | SOLUTION | 1314132 | SOI2LOH54Z | 3.11%w/v | ||
| ZINC OXIDE | SUBCUTANEOUS | INJECTION | 1314132 | SOI2LOH54Z | 0.02%w/v | ||
| ZINC OXIDE | SUBCUTANEOUS | INJECTION, SUSPENSION | 1314132 | SOI2LOH54Z | NA | ||
| ZINC OXIDE | TOPICAL | LOTION | 1314132 | SOI2LOH54Z | 16%w/w | ||
| ZINC STEARATE | BUCCAL | TABLET | 557051 | H92E6QA4FV | 2.5mg | ||
| ZINC STEARATE | ORAL | CAPSULE | 557051 | H92E6QA4FV | 2.04mg | ||
| ZINC STEARATE | ORAL | SYRUP | 557051 | H92E6QA4FV | NA | ||
| ZINC STEARATE | ORAL | TABLET | 557051 | H92E6QA4FV | 72mg | ||
| ZINC STEARATE | ORAL | TABLET, COATED | 557051 | H92E6QA4FV | 1.82mg | ||
| ZINC STEARATE | ORAL | TABLET, EXTENDED RELEASE | 557051 | H92E6QA4FV | 36mg | ||
| ZINC STEARATE | ORAL | TABLET, FILM COATED | 557051 | H92E6QA4FV | 15.2mg | ||
| ZINC STEARATE | SUBLINGUAL | TABLET | 557051 | H92E6QA4FV | 2.5mg | ||
| ZINC STEARATE | TOPICAL | CREAM | 557051 | H92E6QA4FV | 6%w/w | ||
| ZINC STEARATE | TOPICAL | OINTMENT | 557051 | H92E6QA4FV | NA | ||
| ZINC STEARATE | TOPICAL | POWDER | 557051 | H92E6QA4FV | 0.1mg/mg | ||
| ZINC STEARATE | TOPICAL | SHAMPOO | 557051 | H92E6QA4FV | 2%w/w | ||
| ZINC SULFATE | VAGINAL | DOUCHE | 89DS0H96TB | 5%w/w |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024